Polypeptide segment diagnosis model and application thereof in prediction of myeloblastoma metastasis risk
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- AFFILIATED HUSN HOSPITAL OF FUDAN UNIV
- Publication Date
- 2020-12-15
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the field of tumor diagnosis and relates to a novel polypeptide segment medulloblastoma metastasis prediction kit. The kit detects 75 peptide segments in the cerebrospinal fluid and compares them with the cerebrospinal fluid after the initial operation. The method is applied to The prediction of medulloblastoma metastasis can not only guide tumor staging, but also adjust the dose of postoperative chemotherapy according to the possibility of patient metastasis, so as to improve the prognosis of patients. And provide a basis for finding sensitive and specific markers of medulloblastoma in cerebrospinal fluid. Background technique
[0002] Medulloblastoma is the most common malignant brain tumor in children, accounting for about 20% of childhood tumors. The prognosis of adults is also very poor. Medulloblastoma is a serious brain disease that endangers people's health. In 2016, WHO classified medulloblastoma into different molecu...